Gemina Laboratories (XCNQ:GLAB) Interest Expense : C$-0.02 Mil (TTM As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Gemina Laboratories's interest expense for the three months ended in Jan. 2024 was C$ 0.28 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.02 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Gemina Laboratories's Operating Income for the three months ended in Jan. 2024 was C$ -1.04 Mil. Gemina Laboratories's Interest Expense for the three months ended in Jan. 2024 was C$ 0.28 Mil. Gemina Laboratories did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gemina Laboratories Interest Expense Historical Data

The historical data trend for Gemina Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Interest Expense Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Interest Expense

-0.02

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Interest Expense	Get a 7-Day Free Trial							-	-	-	-0.30	0.28

Gemina Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02 Mil.

Gemina Laboratories (XCNQ:GLAB) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gemina Laboratories's Interest Expense for the three months ended in Jan. 2024 was C$0.28 Mil. Its Operating Income for the three months ended in Jan. 2024 was C$-1.04 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2024 was C$0.21 Mil.

Gemina Laboratories's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

GLABF:USA 8I7:Germany

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines